The Determinants Of Leptin Levels In Obese Diabetics and Non-Obese Diabetics: A Population-Based Cross-Sectional Study
DOI:
https://doi.org/10.21276/n70wqw60Keywords:
Leptin and ObesityAbstract
BACKGROUND: There is an established link between Hyperleptinemia and Obesity. Leptin resistance, characterized by elevated levels of circulating leptin together with disruption of hormone signalling, is an important feature of obesity. Hyperleptinemia has been demonstrated to correlate with insulin resistance.
OBJECTIVE: Evaluation of Leptin In Obese and Non-Obese Diabetics.
MATERIAL AND METHODS: This cross-sectional study aimed to evaluate the levels of leptin in non-obese and obese and its relationship. A total of 30 obese diabetics and 30 non-obese diabetics were involved in the study which was conducted in the Department of Physiology, Jawaharlal Nehru Medical College, Aligarh. Collected blood samples were estimated for HbA1C and leptin levels. Body Fat was estimated using Body Stat in Non-Obese Diabetics and Obese Diabetics.
Results: In this study, Leptin levels were significantly higher in obese diabetics compared to non-obese diabetics. Data presents correlations between leptin in obese with HbA1C, BMI, and Body Fat in Obese
Conclusion: Elevated Leptin Levels is a strong marker of obesity which suggests Leptin Resistance.
Downloads
References
Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in
and projections to 2030. Int J Obes (Lond). 2008 Sep;32(9):1431-7.
Després JP. Intra-abdominal obesity: an untreated risk factor for Type 2
diabetes and cardiovascular disease. J Endocrinol Invest. 2006;29(3
Suppl):77-82
Zhou Y, Rui L. Leptin signaling and leptin resistance. Front Med. 2013
Jun;7(2):207-22.
Myers MG Jr, Heymsfield SB, Haft C, Kahn BB, Laughlin M, Leibel RL,
Tschöp MH, Yanovski JA. Challenges and opportunities of defining
clinical leptin resistance. Cell Metab. 2012 Feb 8;15(2):150-6.
Chehab FF. 20 years of leptin: leptin and reproduction: past milestones,
present undertakings, and future endeavors. J Endocrinol. 2014
Oct;223(1):T37-48.
Myers MG Jr, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin
resistance: distinguishing cause from effect. Trends Endocrinol Metab.
Nov;21(11):643-51.
Myers MG Jr, Heymsfield SB, Haft C, Kahn BB, Laughlin M, Leibel RL,
Tschöp MH, Yanovski JA. Challenges and opportunities of defining
clinical leptin resistance. Cell Metab. 2012 Feb 8;15(2):150-6.
Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG,
Mantzoros CS. Leptin in human physiology and therapeutics. Front
Neuroendocrinol. 2010 Jul;31(3):377-93.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research (IABCR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
